Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 248
- Registration Number
- NCT06509724
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Effects of Augmented Reality-based Rapid Blood Transfusion (Level-1®)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT06506851
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
Recruiting
- Conditions
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT06479421
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam, Korea, Republic of
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 88
- Registration Number
- NCT06467097
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT06461819
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT06461793
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT06424808
Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 5461222
- Registration Number
- NCT06406998
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Patritumab Deruxtecan in Patients with Solid Tumor Harboring an NRG1 Fusion
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06383884
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes
Completed
- Conditions
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 3621
- Registration Number
- NCT06357000
© Copyright 2024. All Rights Reserved by MedPath